Inventor · disambiguated record
Yaping Xue
Also filed as: XUE YAPING
15 granted patents·6 pending applications·1 citations·filing 2019–2024
84Inventor score
Files withUNIV ZHEJIANG TECHNOLOGY17GUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO LTD3SUNSHINE LAKE PHARMA CO LTD1
Top patents by PatentIndex Score
21 records- 0184US11001823B2Nitrilase mutants and application thereofUNIV ZHEJIANG TECHNOLOGY·Filed 2019·Granted May 11, 2021·1 cites·5 claims
- 0274US11535839B2Encoding genes of nitrilase mutants and application thereofUNIV ZHEJIANG TECHNOLOGY·Filed 2021·Granted Dec 27, 2022·0 cites·7 claims
- 0374US11525131B2Recombinant vector constructed from an encoding gene of a nitrilase mutant, a recombinant genetic engineered strain and application thereofUNIV ZHEJIANG TECHNOLOGY·Filed 2021·Granted Dec 13, 2022·0 cites·10 claims
- 0469US11939599B2Gene mining method combining functional sequence and structure simulation, NADH-preferring phosphinothricin dehydrogenase mutant and application thereofUNIV ZHEJIANG TECHNOLOGY·Filed 2021·Granted Mar 26, 2024·0 cites·6 claims
- 0568US11781117B2Machine learning gene mining method and phosphinothricin dehydrogenase mutant for amino translocationUNIV ZHEJIANG TECHNOLOGY·Filed 2021·Granted Oct 10, 2023·0 cites·8 claims
- 0666US2025019732A1Method for chemical-biological cascade synthesis of l-phosphinothricin and mutants thereforUNIV ZHEJIANG TECHNOLOGY·Filed 2024·Application pending·0 cites
- 0764US2025163390A1D-amino acid oxidase mutant and application thereof in preparation of l-phosphinothricinUNIV ZHEJIANG TECHNOLOGY·Filed 2023·Application pending·0 cites
- 0862US12428656B2Nitrilase mutant and application thereof in the synthesis of 1-cyanocyclohexyl acetic acidUNIV ZHEJIANG TECHNOLOGY·Filed 2020·Granted Sep 30, 2025·0 cites·7 claims
- 0961US12152264B2Phosphinothricin dehydrogenase mutant, genetically engineered bacterium and one-pot multi-enzyme synchronous directed evolution methodUNIV ZHEJIANG TECHNOLOGY·Filed 2020·Granted Nov 26, 2024·0 cites·8 claims
- 1061US2023242956A1Polyphosphate kinase mutant, engineered strain and application thereofUNIV ZHEJIANG TECHNOLOGY·Filed 2023·Application pending·0 cites
- 1158US11987826B2Nitrilase mutant and application thereof in the synthesis of an anti-epileptic drug intermediateUNIV ZHEJIANG TECHNOLOGY·Filed 2020·Granted May 21, 2024·0 cites·8 claims
- 1257US12104191B2Cofactor self-sufficient Escherichia coli and construction method and application thereofUNIV ZHEJIANG TECHNOLOGY·Filed 2022·Granted Oct 1, 2024·0 cites·8 claims
- 1357US11807883B2Polypeptide tag, highly soluble recombinant nitrilase and application thereof in synthesis of pharmaceutical chemicalsUNIV ZHEJIANG TECHNOLOGY·Filed 2021·Granted Nov 7, 2023·0 cites·3 claims
- 1455US12465047B2Preparation method for L-glufosinate-ammonium powderUNIV ZHEJIANG TECHNOLOGY·Filed 2020·Granted Nov 11, 2025·0 cites·9 claims
- 1555US12031160B2Method for the production of glufosinate-ammoniumUNIV ZHEJIANG TECHNOLOGY·Filed 2019·Granted Jul 9, 2024·0 cites·5 claims
- 1651US2024374615A1Application of steroid compound in preparation of drug for preventing and/or treating eye floatersGUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 1751US2025120910A1Pharmaceutical composition, preparation method therefor and application thereofGUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 1850US12215372B2Method for asymmetrically preparing L-phosphinothricin by oxidation-reduction reaction through biological multi-enzyme couplingUNIV ZHEJIANG TECHNOLOGY·Filed 2020·Granted Feb 4, 2025·0 cites·10 claims
- 1950US2024315995A1Application of loxoprofen sodium in preparation of drug for treating dry eye diseaseGUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 2049US11408016B2Amino acid dehydrogenase mutant and application in synthesis of L-glufosinate-ammonium thereofUNIV ZHEJIANG TECHNOLOGY·Filed 2019·Granted Aug 9, 2022·0 cites·7 claims
- 2147US11858910B2Pyridinylmethylenepiperidine derivatives and uses thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2019·Granted Jan 2, 2024·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Yaping Xue files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →